OQS
FLGT icon

Occudo Quantitative Strategies’s Fulgent Genetics FLGT Stock Holding History

Occudo Quantitative Strategies’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,437
Closed -$224K – 807
2024
Q2 		$224K Sell
11,437
-4,538
-28% -$94.7K 0.04% 558
2024
Q1 		$347K Sell
15,975
-10,765
-40% -$267K 0.06% 422
2023
Q4 		$773K Buy
+26,740
New +$715K 0.11% 264
2023
Q3 		– Sell
-24,400
Closed -$904K – 1082
2023
Q2 		$904K Buy
24,400
+12,862
+111% +$448K 0.09% 367
2023
Q1 		$360K Buy
11,538
+4,589
+66% +$148K 0.03% 604
2022
Q4 		$207K Buy
+6,949
New +$249K 0.02% 767

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Occudo Quantitative Strategies's FLGT Position: Q3 2024 in Review

Occudo Quantitative Strategies sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 11,437 shares — an estimated $224K sold.

Occudo Quantitative Strategies first reported a position in FLGT in Q4 2022 and held it in 6 quarters. The position peaked at $904K in Q2 2023. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

  • Occudo Quantitative Strategies reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 11,437 Fulgent Genetics shares in Q3 2024, an estimated $224K.
  • Occudo Quantitative Strategies first reported a position in Fulgent Genetics in Q4 2022 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Fulgent Genetics position peaked at $904K in Q2 2023.
  • 183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.